Aytu Biopharma Inc (AYTU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 15,147 | 13,520 | 14,861 | 8,156 | 3,175 |
| Cost of Goods | 6,251 | 4,063 | 5,301 | 1,999 | 606 |
| Gross Profit | 8,896 | 9,457 | 9,560 | 6,158 | 2,569 |
| Operating Expenses | 14,722 | 13,077 | 16,496 | 11,950 | 8,142 |
| Operating Income | -5,575 | -3,557 | -6,635 | -4,793 | -4,967 |
| Other Income | -3,950 | -749 | 3,490 | -539 | 4,753 |
| Pre-tax Income | -9,525 | -4,306 | -3,145 | -5,332 | -214 |
| Net Income Continuous | -9,525 | -4,306 | -3,145 | -5,332 | -214 |
| Net Income | $-9,525 | $-4,306 | $-3,145 | $-5,332 | $-214 |
| EPS Basic Total Ops | -14.40 | -7.00 | 36.40 | -30.20 | -2.40 |
| EPS Basic Continuous Ops | -14.34 | -7.08 | 36.71 | -30.23 | -2.44 |
| EPS Diluted Total Ops | -14.40 | -7.00 | 36.40 | -30.20 | -2.40 |
| EPS Diluted Continuous Ops | -14.34 | -7.08 | 36.71 | -30.23 | -2.44 |
| EBITDA(a) | $-3,658 | $-1,437 | $-4,169 | $-3,171 | $-3,679 |